Showing results (261-270 of 273) with videos related to
Sort By:
Pageof 28
Journal of Clinical and Experimental Neuropsychology|February 26, 2010
Self-report of cognitive impairment and mini-mental state examination performance in PRKN, LRRK2, and GBA carriers with early onset Parkinson's diseaseRoy N Alcalay, Helen Mejia-Santana, Ming X Tang, et al.Molecular Neurodegeneration|November 26, 2024
The Parkinson's disease risk gene cathepsin B promotes fibrillar alpha-synuclein clearance, lysosomal function and glucocerebrosidase activity in dopaminergic neuronsJace Jones-Tabah, Kathy He, Nathan Karpilovsky, et al.Brain : a Journal of Neurology|April 15, 2021
COVID-19 neuropathology at Columbia University Irving Medical Center/New York Presbyterian HospitalKiran T Thakur, Emily Happy Miller, Michael D Glendinning, et al.Journal of the International Neuropsychological Society : JINS|November 25, 2010
Neuropsychological Profile of Parkin Mutation Carriers with and without Parkinson Disease: The CORE-PD StudyElise Caccappolo, Roy N Alcalay, Helen Mejia-Santana, et al.Archives of Neurology|June 19, 2010
Predictors of parkin mutations in early-onset Parkinson disease: the consortium on risk for early-onset Parkinson disease studyKaren S Marder, Ming X Tang, Helen Mejia-Santana, et al.JAMA Neurology|November 6, 2013
Cognitive and motor function in long-duration PARKIN-associated Parkinson diseaseRoy N Alcalay, Elise Caccappolo, Helen Mejia-Santana, et al.Movement Disorders : Official Journal of the Movement Disorder Society|February 22, 2019
SMPD1 mutations, activity, and α-synuclein accumulation in Parkinson's diseaseRoy N Alcalay, Victoria Mallett, Benoît Vanderperre, et al.Movement Disorders : Official Journal of the Movement Disorder Society|November 19, 2013
Parkinson disease phenotype in Ashkenazi Jews with and without LRRK2 G2019S mutationsRoy N Alcalay, Anat Mirelman, Rachel Saunders-Pullman, et al.Archives of Neurology|July 21, 2004
Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trialRobert G Holloway, Ira Shoulson, Stanley Fahn, et al.Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 31, 2021
Biallelic and monoallelic variants in PLXNA1 are implicated in a novel neurodevelopmental disorder with variable cerebral and eye anomaliesGabriel C Dworschak, Jaya Punetha, Jeshurun C Kalanithy, et al.Pageof 28